Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV005271156 | SCV005935224 | uncertain significance | Inborn genetic diseases | 2025-02-25 | criteria provided, single submitter | clinical testing | The c.593A>G (p.Y198C) alteration is located in exon 2 (coding exon 2) of the RP2 gene. This alteration results from a A to G substitution at nucleotide position 593, causing the tyrosine (Y) at amino acid position 198 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
| Labcorp Genetics |
RCV001320508 | SCV001511297 | likely benign | not provided | 2024-12-02 | criteria provided, single submitter | clinical testing |